Congress won’t include PhRMA-backed Medicare change in opioids package

PhRMA’s been trying all year to get Congress to relieve the industry of some of its responsibility for certain Medicare drug costs. It just lost again.
House Speaker Paul Ryan (R-Wis.) Source: Astrid Riecken/Getty Images

WASHINGTON — The latest version of a bill to address the opioid crisis will not include an unrelated, drug industry-backed provision that would relieve drug companies of some of their responsibility for certain Medicare drug costs, multiple lobbyists with knowledge of the bill told STAT.

The bill also will not include any version of the CREATES Act, a long-stalled bill to incentivize the production of cheaper generic and biosimilar drugs.

The opioids legislation, which

You're reading a preview, sign up to read more.

More from STAT

STAT2 min readSociety
More Than 15% Of U.S. Adults Are Physically Inactive, New CDC Data Show
More than 1 in 7 adults across all U.S. states and territories are physically inactive, new CDC data show.
STAT6 min read
Opinion: Goop’s Pseudoscience Ministry Comes To Netflix
Gwyneth Paltrow's Goop has embraced mediums and mysticism. With spirits and the divine on board, "The Goop Lab" on Netflix has the missing ingredients to cement lifestyle as the new…
STAT6 min read
‘Donation After Cardiac Death’: New Heart Transplant Method Being Tested For The First Time In The U.S.
A new method of “reanimating” donor hearts from those who have died from cardiac failure is being tested in the U.S. and may be able to expand amount of people…